Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9106 |
High Similarity |
NPD422 |
Phase 1 |
0.8855 |
High Similarity |
NPD5124 |
Phase 1 |
0.8855 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8626 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.854 |
High Similarity |
NPD1652 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8195 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8168 |
Intermediate Similarity |
NPD3225 |
Approved |
0.806 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8017 |
Intermediate Similarity |
NPD9697 |
Approved |
0.797 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7958 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7951 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7941 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7939 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7929 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7886 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7879 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7877 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7863 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7852 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7832 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7817 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.781 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7801 |
Intermediate Similarity |
NPD2796 |
Approved |
0.78 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7794 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7763 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7762 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD290 |
Approved |
0.774 |
Intermediate Similarity |
NPD5401 |
Approved |
0.773 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7717 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7708 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7704 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7698 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7698 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7681 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7652 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7643 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7606 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7571 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7556 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7554 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.754 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7533 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7519 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7518 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD5402 |
Approved |
0.75 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7483 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7483 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7465 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7447 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7445 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7445 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7444 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7432 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7432 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD1048 |
Approved |
0.741 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7403 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD920 |
Approved |
0.7397 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7391 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7385 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7379 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7379 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7379 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7379 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7379 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7376 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7357 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7339 |
Intermediate Similarity |
NPD940 |
Approved |
0.7339 |
Intermediate Similarity |
NPD846 |
Approved |
0.7338 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7319 |
Intermediate Similarity |
NPD6362 |
Approved |
0.731 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD411 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7273 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7273 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7254 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD968 |
Approved |
0.7244 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7241 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7218 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7214 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7206 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7197 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7192 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7192 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7179 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7176 |
Intermediate Similarity |
NPD821 |
Approved |
0.7174 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7152 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7113 |
Intermediate Similarity |
NPD5163 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7101 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7101 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7051 |
Intermediate Similarity |
NPD37 |
Approved |
0.705 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.705 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.705 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7048 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD919 |
Approved |
0.7042 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7039 |
Intermediate Similarity |
NPD3536 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7034 |
Intermediate Similarity |
NPD1933 |
Approved |
0.703 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD3691 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD3690 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD5647 |
Approved |
0.702 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7013 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7013 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7006 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD3180 |
Approved |
0.6993 |
Remote Similarity |
NPD3179 |
Approved |
0.6993 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD6273 |
Approved |
0.6986
|
Remote Similarity |
NPD6651 |
Approved |